29 January 2026

Judges Scientific plc

("Judges Scientific" or the "Company")

Grant of Options

Judges Scientific announces that it has issued options under the 2025 share option schemes over 81,600 new ordinary shares of 5 pence each in the Company ("Ordinary Shares") at an exercise price per share of £52.00, being the closing mid-price on 27 January 2026.

The Remuneration Committee have awarded, both in recognition of the appointment of Tim Prestidge to Chief Executive on 9 February 2026 and in accordance with its policy of annual awards of share options to retain and incentivise the Executive Directors, the share options as shown in the table below. Vesting of these options after three years is subject to the achievement of 5% compound growth in adjusted earnings per share over the vesting period, and to continued employment.

For further information please contact: 

Notes to editors:

Judges Scientific plc (AIM: JDG), is a group focused on acquiring and developing companies in the scientific instrument sector.  The Group consists of 25 businesses acquired since 2005.

The acquired companies are primarily UK-based with products sold worldwide to a diverse range of markets including higher education institutions, scientific research facilities, manufacturers, and regulatory authorities.  The UK is a recognised centre of excellence for scientific instruments.  The Group has received five Queen's Awards for Innovation and Export.

The Group's companies predominantly operate in global niche markets, with long term growth fundamentals and resilient margins.

Judges Scientific maintains a policy of selectively acquiring businesses that generate sustainable profits and cash.  Shareholder returns are created through the reduction of debt, organic growth, and dividends.

For further information, please visit www.judges.uk.com